Thomas Ihle - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Thomas Ihle

Showing results (21-30 of 25) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 25 results.

Physical Review. E|November 16, 2021

Phases and homogeneous ordered states in alignment-based self-propelled particle modelsYinong Zhao, Thomas Ihle, Zhangang Han, et al.

Bioorganic Chemistry|April 19, 2019

Potent and selective EGFR inhibitors based on 5-aryl-7H-pyrrolopyrimidin-4-aminesAnn Christin Reiersølmoen, Thomas Ihle Aarhus, Sarah Eckelt, et al.

European Journal of Medicinal Chemistry|December 23, 2023

Pyrrolopyrimidine based CSF1R inhibitors: Attempted departure from FlatlandFrithjof Bjørnstad, Simen Havik, Thomas Ihle Aarhus, et al.

European Journal of Medicinal Chemistry|May 4, 2023

A highly selective purine-based inhibitor of CSF1R potently inhibits osteoclast differentiationThomas Ihle Aarhus, Jan Eickhoff, Bert Klebl, et al.

Journal of Medicinal Chemistry|May 16, 2023

Synthesis and Development of Highly Selective Pyrrolo[2,3-<i>d</i>]pyrimidine CSF1R Inhibitors Targeting the Autoinhibited FormThomas Ihle Aarhus, Frithjof Bjørnstad, Camilla Wolowczyk, et al.

Pageof 3

Search research articles

Showing results (21-30 of 25) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 25 results.

Physical Review. E|November 16, 2021

Phases and homogeneous ordered states in alignment-based self-propelled particle modelsYinong Zhao, Thomas Ihle, Zhangang Han, et al.

Bioorganic Chemistry|April 19, 2019

Potent and selective EGFR inhibitors based on 5-aryl-7H-pyrrolopyrimidin-4-aminesAnn Christin Reiersølmoen, Thomas Ihle Aarhus, Sarah Eckelt, et al.

European Journal of Medicinal Chemistry|December 23, 2023

Pyrrolopyrimidine based CSF1R inhibitors: Attempted departure from FlatlandFrithjof Bjørnstad, Simen Havik, Thomas Ihle Aarhus, et al.

European Journal of Medicinal Chemistry|May 4, 2023

A highly selective purine-based inhibitor of CSF1R potently inhibits osteoclast differentiationThomas Ihle Aarhus, Jan Eickhoff, Bert Klebl, et al.

Journal of Medicinal Chemistry|May 16, 2023

Synthesis and Development of Highly Selective Pyrrolo[2,3-<i>d</i>]pyrimidine CSF1R Inhibitors Targeting the Autoinhibited FormThomas Ihle Aarhus, Frithjof Bjørnstad, Camilla Wolowczyk, et al.

Pageof 3